Ciambra
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ciambra, covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: EMA Withdrawn: Ciambra (pemetrexed disodium hemipentahydrate) — Menarini International Operations Luxembourg S.A.